Influence of Timing PTCy in AlloSCT

NCT05886335 · clinicaltrials.gov ↗

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Cyclophosphamide Toxicity
Allogenic Haematopoetic Transplantation

Interventions

DRUG: Cyclophosphamide

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau